• 1
    Nobbenhuis MAE, Walboomers JMM, Helmerhorst ThJM, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999;354: 2025.
  • 2
    Rozendaal L, Walboomers JMM, van der Linden JC, et al. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer 1996;68: 766769.
  • 3
    Liaw K, Glass AG, Manos MM, et al. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst 1999;91: 954960.
  • 4
    Hopman EH, Rozendaal L, Voorhorst FJ, Walloomers JMM, Kenemans P, Helmerhorst ThJM. High risk human papillomavirus in women with normal cervical cytology prior to the development of abnormal cytology and colposcopy. Br J Obstet Gynaecol. 2000: 600604.
  • 5
    Zielinski GD, Snijders PJF, Rozendaal L, et al. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears. Br J Cancer 2001;85: 398404.
  • 6
    Wallin K, Wiklund F, Angstrom T, et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999;341: 16331638.
  • 7
    Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327: 12721278.
  • 8
    Moscicki A, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001;285: 29953002.
  • 9
    Woodman CBJ, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001;357: 18311836.
  • 10
    Remmink AJ, Walboomers JMM, Helmerhorst ThJM, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995;61: 306311.
  • 11
    Ylitalo N, Josefsson A, Melbye M, et al. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ. Cancer Res 2000;60: 60276032.
  • 12
    Coker A, Gerasimova T, King MR, Jackson KL, Pirisi L. High-risk HPVs and risk of cervical neoplasia: a nested case–control study. Exp Mol Pathol 2001;70: 9095.
  • 13
    Kataja V, Syrjanen A, Mantyjarvi R, Yliskoski H, Saarikoski S, Syrjanen K. Prognostic factors in cervical human papillomavirus infections. Sex Transm Dis 1992;19: 154160.
  • 14
    Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338: 423428.
  • 15
    Woodman CBJ, Rollason T, Ellis J, Tierney R, Wilson S, Young L. Human papillomavirus infection and risk of progression of epithelial abnormalities of the cervix. Br J Cancer 1996;73: 553556.
  • 16
    Liu T, Soong S, Alvarez RD, Butterworth CE. A longitudinal analysis of human papillomavirus 16 infection, nutritional status, and cervical dysplasia progression. Cancer Epidemiol Biomarkers Prev 1995;4: 373380.
  • 17
    Campion MJ, Cuzick J, McCance DJ, Singer A. Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet 1986;11: 237240.
  • 18
    Byrne MA, Parry GCN, Morse A, Taylor-Robinson D, Malcolm ADB, Coleman DV. A prospective study of human papillomavirus infection of the cervix. Cytopathology 1990;1: 329337.
  • 19
    Caussy D, Marrett LD, Worth AJ, McBride M, Rawls WE. Human papillomavirus and cervical intraepithelial neoplasia in women who subsequently had invasive cancer. Can Med Assoc J 1990;142: 311317.
  • 20
    Weaver MG, Abdul-Karim FW, Dale G, Sorensen K, Huang YT. Outcome in mild and moderate cervical dysplasias related to the presence of specific human papillomavirus types. Mod Pathol 1990;3: 679683.
  • 21
    Badaracco G, Giovinazzi R, Sedati A, Venuti A, Marcante ML. A follow-up study on human papillomavirus types 16 and 18 infections and cervical neoplasia. J Exp Clin Cancer Res 1992;11: 259262.
  • 22
    Pich A, Margaria E, Ghiringhello B, Navone R. In situ hybridization for human papillomavirus as a method of predicting the evolution of cervical intraepithelial neoplasia. Arch Gynecol Obstet 1992;252: 1119.
  • 23
    Stellato G, Nieminen P, Aho H, Vesterinen E, Vaheri A, Paavonen J. Human papillomavirus infection of the female genital tract: correlation of HPV DNA with cytologic, colposcopic, and natural history findings. Eur J Gynaecol Oncol 1992;3: 262267.
  • 24
    Hellberg D, Nilsson S, Grad A, et al. Behavior of cervical intraepithelial neoplasia (CIN) associated with various human papillomavirus (HPV) types. Arch Gynecol Obstet 1993;252: 119128.
  • 25
    Downey GP, Bavin PJ, Deery ARS, et al. Relation between human papillomavirus type 16 and potential for progression of minor-grade cervical disease. Lancet 1994;344: 432435.
  • 26
    Gaarenstroom KN, Melkert P, Walboomers JMM, et al. Human papillomavirus DNA and genotypes: prognostic factors for progression of cervical intraepithelial neoplasia. Int J Gynecol Cancer 1994;4: 7378.
  • 27
    Flannelly G, Jiang G, Anderson D, Melvin W, Mann E, Kitchener H. Serial quantitation of HPV-16 in the smears of women with mild and moderate dyskaryosis. J Med Virol 1995;47: 69.
  • 28
    Iwasaka T, Matsuo N, Yokoyama M, Sugimori H. Non-detection of human papillomavirus DNA in cervical dysplasia and disease progression. Lancet 1996;348: 333.
  • 29
    Hording U, Junge J, Rygaard C, Lundvall F. Management of low-grade CIN: follow-up or treatment?. Eur J Obstet Gynecol Reprod Biol 1995;62: 4952.
  • 30
    Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C, Singer A. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer (Pred Oncol) 1996;69: 364368.
  • 31
    Shah KV, Kessis TD, Shah F, Gupta JW, Shibata D, Jones RW. Human papillomavirus investigation of patients with cervical intraepithelial neoplasia 3, some of whom progressed to invasive cancer. Int J Gynecol Pathol 1996;15: 127130.
  • 32
    Paraskevaidis E, Kalantaridou SN, Georgiou I, et al. Spontaneous evolution of human papillomavirus infection in the uterine cervix. Anticancer Res 1999;19: 34733478.
  • 33
    Ter Harmsel B, Smedts F, Kuijpers J, van Muyden R, Oosterhuis W, Quint W. Relationship between human papillomavirus type 16 in the cervix and intraepithelial neoplasia. Obstet Gynecol 1999;93: 4650.
  • 34
    Clavel C, Masure M, Levert M, et al. Human papillomavirus detection by the hybrid capture II assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions. Diagn Mol Pathol 2000;9: 145150.
  • 35
    Anon. Human Papilomavirus Lyon : International Agency for Research on Cancer, 1995: 64.
  • 36
    Cuzick J, Sasieni P, Davis P, et al. A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess 1993;3(14):3549.
  • 37
    Romney SL, Ho GY, Palan PR, et al. Effects of beta-carotene and other factors on outcome of cervical dysplasia and human papillomavirus infection. Gynecol Oncol 1997;65: 483492.
  • 38
    Moscicki AB, Shiboski S, Broering J, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998;132: 277284.
  • 39
    Moscicki AB, Palefsky J, Smith G, Siboshski S, Schoolnik G. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol 1993;82: 578585.
  • 40
    Walboomers JM, Husman AM, Snijders PJ, et al. Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer. J Clin Pathol 1995;48: 728732.
  • 41
    Kataja V, Syrjanen K, Syrjanen S, et al. Prospective follow-up of genital HPV infections: survival analysis of the HPV typing data. Eur J Epidemiol 1990;6: 914.
  • 42
    Lorincz AT, Schiffman MH, Jaffurs WJ, Marlow J, Quinn AP, Temple GF. Temporal associations of human papillomavirus infection with cervical cytologic abnormalities. Am J Obstet Gynecol 1990;162: 645651.
  • 43
    De Villiers EM, Wagner D, Schneider A, et al. Human papillomavirus DNA in women without and with cytological abnormalities: results of a 5-year follow-up study. Gynecol Oncol 1992;44: 3339.
  • 44
    Parry G, Byrne M, Morse A, Coleman DV, Taylor-Robinson D, Malcolm ADB. Human papillomavirus infection of the cervix—the results of a prospective study. In: HowleyPN, BrokerTR, editors. Papillomaviruses. New York : Wiley-Liss, 1990: 1320.
  • 45
    Chua KL, Hjerpe A. Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma. Cancer 1996;77: 121127.
  • 46
    Franco EL. Measurement errors in epidemiological studies of human papillomavirus and cervical cancer. In: MunozN, BoschFX, ShahKV, MeheusA, editors. . The Epidemiology of Human Papillomavirus and Cervical Cancer. Lyon : IARC, 1992: 181197.
  • 47
    Chenoy R, Billingham L, Irani S, Rollason TP, Luesley DM, Jordan JA. The effect of directed biopsy on the atypical cervical transformation zone: assessed by digital imaging colposcopy. Br J Obstet Gynaecol 1996;103: 457462.
  • 48
    Cohort studies. In: RothmanKJ, GreenlandS, editors. Modern Epidemiology, 2nd edition. Philadelphia : Lippincott-Raven, 1998: 7991.
  • 49
    Stubenrauch F, Laimins LA. Human papillomavirus life cycle: active and latent phases. Semin Cancer Biol 1999;9: 379386.